Radiation Oncology

Breast Cancer, Metastatic

Questions discussed in this category

What are your top takeaways in Breast Cancer from ASCO 2022?

What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical practice? ...

12 Answers available

For a young patient who had a prior pCR to neoadjuvant therapy, would you consider systemic therapy after local resection and radiation of an isolated brain metastatic recurrence of triple negative breast cancer?

CNS recurrence occurred within two years of prior neoadjuvant therapy

1 Answer available

Papers discussed in this category

N. Engl. J. Med.,

Pembrolizumab for Early Triple-Negative Breast Cancer.

N Engl J Med,

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

N Engl J Med, 2022 Jun 05

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

J Natl Compr Canc Netw, 2021 Mar 24

Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.

N Engl J Med,

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Related Topics in Radiation Oncology